BioCryst Pharmaceuticals, Inc. Common Stock BCRX
i
Market dataready · fetched 2026-11-04T02:46:46.336Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-04T00:11:02.098151666Z
FundamentalsSEC EDGAR · ready · as of 2026-06-30 · fetched 2026-11-04T02:46:45.814063+00:00
BioCryst Pharmaceuticals, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 7.42 | 79.6% | 14.9% | |||
| 25Δ | 7.74 | 70.1% | 11.5% | |||
| 30Δ | 9.31 | 62.8% | 11.7% | 8.03 | 63.9% | 8.7% |
| 35Δ | 9.10 | 62.6% | 9.8% | 8.23 | 73.3% | 8.3% |
| 40Δ | 8.92 | 63.1% | 8.4% | 8.43 | 82.7% | 8.0% |
| 45Δ | 8.76 | 64.0% | 7.5% | 8.63 | 92.1% | 7.6% |
| 50Δ | 8.61 | 64.9% | 6.7% | 8.83 | 101.5% | 7.3% |
| 55Δ | 8.45 | 65.9% | 5.8% | 9.04 | 109.0% | 6.8% |
| 60Δ | 8.30 | 66.8% | 4.9% | 9.30 | 106.4% | 5.8% |
| 65Δ | 8.14 | 67.7% | 4.1% | |||
| 70Δ | ||||||
| 75Δ | 13.34 | 228.3% | 5.9% | |||
| 80Δ | 13.64 | 206.8% | 4.1% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.42
- IV
- 79.6%
- B/E move
- 14.9%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.74
- IV
- 70.1%
- B/E move
- 11.5%
30Δ
- Pseudo strike
- 9.31
- IV
- 62.8%
- B/E move
- 11.7%
- Pseudo strike
- 8.03
- IV
- 63.9%
- B/E move
- 8.7%
35Δ
- Pseudo strike
- 9.10
- IV
- 62.6%
- B/E move
- 9.8%
- Pseudo strike
- 8.23
- IV
- 73.3%
- B/E move
- 8.3%
40Δ
- Pseudo strike
- 8.92
- IV
- 63.1%
- B/E move
- 8.4%
- Pseudo strike
- 8.43
- IV
- 82.7%
- B/E move
- 8.0%
45Δ
- Pseudo strike
- 8.76
- IV
- 64.0%
- B/E move
- 7.5%
- Pseudo strike
- 8.63
- IV
- 92.1%
- B/E move
- 7.6%
50Δ
- Pseudo strike
- 8.61
- IV
- 64.9%
- B/E move
- 6.7%
- Pseudo strike
- 8.83
- IV
- 101.5%
- B/E move
- 7.3%
55Δ
- Pseudo strike
- 8.45
- IV
- 65.9%
- B/E move
- 5.8%
- Pseudo strike
- 9.04
- IV
- 109.0%
- B/E move
- 6.8%
60Δ
- Pseudo strike
- 8.30
- IV
- 66.8%
- B/E move
- 4.9%
- Pseudo strike
- 9.30
- IV
- 106.4%
- B/E move
- 5.8%
65Δ
- Pseudo strike
- 8.14
- IV
- 67.7%
- B/E move
- 4.1%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 13.34
- IV
- 228.3%
- B/E move
- 5.9%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 13.64
- IV
- 206.8%
- B/E move
- 4.1%
Options history
Table
| Date | IV (%) |
|---|---|
| 77.73% | |
| 61.99% | |
| 63.71% | |
| 69.01% | |
| 57.39% | |
| 54.28% | |
| 73.25% | |
| 82.27% | |
| 56.34% | |
| 57.27% |
Drug Manufacturers - Specialty & Generic
BHC
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of…
More →BIOA
BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United States and Canada. The…
More →CGC
Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the…
More →COLL
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
More →CPIX
Description unavailable
More →CRDL
Cardiol Therapeutics Inc., a clinical-phase biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular…
More →